Last $6.25 USD
Change Today -0.07 / -1.11%
Volume 152.4K
OCAT On Other Exchanges
Symbol
Exchange
OTC US
Stuttgart
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gary H. Rabin

Former Chairman and Member of Nominating & Corporate Governance Committee, Ocata Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

49$551,250
As of Fiscal Year 2013

Background*

Mr. Gary H. Rabin serves as Managing Partner of Vine Holdings. Mr. Rabin served as the Chief Executive Officer of Advanced Cell Technology Inc. from December 14, 2010 to January 21, 2014. Mr. Rabin served as Principal Financial Officer of Advanced Cell Technology Inc., since May 2013 and also served as its Principal Accounting Officer and Interim Chief Executive Officer. Mr. Rabin served as a Portfolio Manager of MAC Investment Management, LLC ("MAC") until July 2007, ...

Read Full Background

Corporate Headquarters*

33 Locke Drive
Marlborough, Massachusetts 01752

United States

Phone: 508-756-1212
Fax: 508-229-2333

Board Members Memberships*

2007-2014
Former Chairman and Member of Nominating & Corporate Governance Committee

Education*

BA
University of Michigan

Other Affiliations*

Annual Compensation*

Salary$551,250
Total Annual Compensation$551,250

Stock Options*

Exercisable Options250,000
Total Number of Options250,000

Total Compensation*

Total Annual Cash Compensation$551,250
Total Short Term Compensation$551,250
Total Calculated Compensation$551,250
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OCAT:US $6.25 USD -0.07

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Olav Hellebo Chief Executive Officer
ReNeuron Group plc
--
Zami Aberman Executive Chairman and Chief Executive Officer
Pluristem Therapeutics, Inc.
$503.7K
I. Richard Garr J.D.Co-Founder, Chief Executive Officer, President, Chief Financial Officer, Principal Accounting Officer, General Counsel and Director
Neuralstem, Inc.
$651.2K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OCATA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.